Background and Objective
The present study was designed to validate the functional assay that enables rapid screening of therapeutic candidates for their effect on mitochondrial fatty acid oxidation.
The two whole-cell systems (tissue homogenates and hepatocytes) have been evaluated to monitor the total beta-oxidation flux of physiologically important 3H-palmitic acid by measurement of tritiated water enrichment in incubations using UPLC coupled on-line to radioactivity monitoring and mass spectrometry.
Our results with several known inhibitors of fatty acid oxidation showed that this simple assay could correctly predict a potential in alteration of mitochondrial function by drug candidates. Since the beta-oxidation of palmitic acid takes place almost exclusively in mitochondria of human hepatocytes, this model can be also utilized to distinguish between the mitochondrial and peroxisomal routes of this essential metabolic pathway in some cases.
The present work offers a new in vitro screen of changes in mitochondrial beta-oxidation by xenobiotics as well as a model to study the mechanism of this pathway.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Youssef JA, Song WO, Badr MZ. Mitochondrial, but not peroxisomal, beta-oxidation of fatty acids is conserved in coenzyme A deficient rat liver. Mol Cell Biochem. 1997;175:37–42.
Hettema EH, Henk FT. Transport fatty acids and metabolites across the peroxisomal membrane. Biochim Biophys Acta. 2000;1486:18–27.
Kemp S, Theodoulou FL, Wanders RJA. Mammalian peroxisomal ABC transporters: from endogenous substrates to pathology and clinical significance. Br J Pharmacol. 2011;164(7):1753–66.
Mannaerts GP, Van Veldhoven PP. Influence of drugs on liver mitochondria and peroxisomes. Arch Toxicol Suppl. 1988;12:225–32.
Wanders RJA, Ruiter JPN, Lodewijk IJI, Waterham HR, Houten SM. The enzymology of mitochondrial fatty acid beta-oxidation and its application to follow up analyses of positive neonatal screening results. J Inherit Metab Dis. 2010;33(5):479–94.
Poirier Y. Antonenkov, Glumoff, Hiltunen. Peroxisomal beta-oxidation—a metabolic pathway with multiple functions. Biochim Biophys Acta. 2006;1764:1413–26.
Fromenty B, Pessayre D. Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity. Pharmacol Ther. 1995;67(1):101–54.
Begriche K, Massart J, Robin M-A, Borgne-Sanchez A, Fromenty B. Drug-induced toxicity on mitochondria and lipid metabolism: mechanistic diversity and deleterious consequences for the liver. J Hepatol. 2011;54:77–94.
Carracedo A, Cantley LC, Pandolfi PP. Cancer metabolism: fatty acid oxidation in the limelight. Nat Rev Cancer. 2013;13(4):227–32.
Vishwanath VA. Fatty acid beta-oxidation disorders: a brief review. Ann Neurosci. 2016;23:51–5.
Agius L, Peak M, Sherratt HAS. Difference between human, rat and guinea pig hepatocyte cultures; a comparative study of their rates of beta-oxidation and esterification of palmitate and their sensitivity to R-etomoxir. Biochem Pharmacol. 1991;42(9):1711–5.
Eaton S. Control of mitochondrial beta oxidation flux. Prog Lipid Res. 2002;41:197–239.
Rioux V, Lemarchal P, Legrand P. Myristic acid, unlike palmitic acid is readily metabolized in cultured rat hepatoctyes. J Nutr Biochem. 2000;11:198–207.
Law LK, Nelson LST, Hui J, Ho ChS, Ruiter J, Fok TF, et al. A novel functional assay for simultaneous determination of total fatty acid beta-oxidation flux and acylcarnitine profiling in human skin fibroblast using 2H31-palmitate by isotope ratio mass spectrometry and electrospray tandem mass spectrometry. Clin Chem Acta. 2007;382:25–30.
Seargeant LE, Balachandra K, Dilling LA, Greenberg CR. A simple screening test for fatty acid oxidation defects using whole-blood palmitate oxidation. J Inherit Metab Dis. 1999;22:740–6.
Norden M, Westman O, Venizelos N, Engwall M. Perfluorooctane sulfonate increases beta-oxidation of palmitic acid in chicken liver. Environ Sci Pollut Res. 2012;19:1859–63.
Westman O, Larsson M, Venizelos N, Hollert H, Magnus E. An oxygenated metabolite of benzo[a]pyrene increases hepatic beta-oxidation of fatty acids in chick embryos. Environ Sci Pollut Res. 2014;21(9):6243–51.
Hirschey MD, Verdin E. Measuring fatty acid oxidation in tissue homogenates. In: Nature publishing group. 2010. http://www.nature.com/protocolexchange/protocols/631. Accessed 10 Jan 2018.
Moffat C, Bhatia L, Nguyen T, Lynch P, Wang M, Wang D, et al. Acyl-CoA thioesterase-2 facilitates mitochondrial fatty acid oxidation in the liver. J Lipid Res. 2014;12:2458–70.
Harris FT, Jamshedur Rahman SM, Hassanein M, Qian J, Hoeksema MD, Chen H, et al. Acyl-coenzyme A-binding protein regulates beta-oxidation required for growth and survival of non-small cell lung cancer. Cancer Prev Res. 2014;7(7):748–57.
Jiang Z, Knudsen NH, Wang G, Qiu W, Chi Naing ZZ, Bai Y, et al. Genetic control of fatty acid beta-oxidation in chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2017;56(6):738–48.
Tirado-Velez JM, Jourmady I, Saez-Benito A, Cozar-Casellano I, German P. Inhibition of fatty acid metabolism reduces human myeloma cells proliferation. PloS one. 2012;7(9):e46484.
Schermuly RT, Schultz A, Ghofrani HA, Meidow A, Rose F, Roehl A, et al. Pharmacokinetics and metabolism of infused versus inhaled iloprost in isolated rabbit lungs. J Pharmacol Exp Ther. 2002;303(2):741–5.
Yu XX, Drackley JK, Odle J. Rates of mitochondrial and peroxisomal beta-oxidation of palmitate change during postnatal development and food deprivation in liver, kidney and heart of pigs. J Nutr. 1997;127(9):1814–21.
Kondrup J, Lazarow PB. Flux of palmitate through the peroxisomal and mitochondrial beta-oxidation systems in isolated rat hepatocytes. Biochim Biophys Acta. 1985;835(1):147–53.
Kler RS, Jackson S, Bartlett K, Bindoff L, Eaton S, Pourfarzam M, et al. Quantitation of acyl-CoA and acylcarnitine esters accumulated during abnormal mitochondrial fatty acid oxidation. J Biol Chem. 1991;266(34):22932–8.
Fréneaux E, Labbe G, Letteron P, Le Dinh The, Degott C, Genève J, et al. Inhibition of the mitochondrial oxidation of fatty acids by tetracycline in mice and in man: possible role in microvesicular steatosis induced by this antibiotic. Hepatology. 1988;8(5):1056–62.
Fromenty B, Fisch C, Labbe G, Degott C, Deschamps D, Berson A, et al. Amiodarone inhibits the mitochondrial beta-oxidation of fatty acids and produces microvesicular steatosis of the liver in mice. J Pharmacol Exp Ther. 1990;255(3):1371–6.
Browne GS, Nelson C, Nguyen T, Ellis BA, Day RO, Williams KM. Stereoselective and substrate-dependent inhibition of hepatic mitochondrial beta-oxidation and oxidative phosphorylation by the non-steroidal anti-inflammatory drugs ibuprofen, flurbiprofen and ketorolac. Biochem Pharmacol. 1999;57:837–44.
Amacher DE, Martin BA. Tetracycline-induced steatosis in primary canine hepatocyte cultures. Fundam Appl Toxicol. 1997;40(2):256–63.
Tyni T, Pourfarzam M, Turnbull DM. Analyses of mitochondrial fatty acid oxidation intermediates by tandem mass spectrometry from intact mitochondria prepared from homogenates of cultured fibroblasts, skeletal muscle cells, and fresh muscle. Pediatr Res. 2002;52(1):64–70.
Savir Y, Tu BP, Springer M. Competitive inhibition can linearize dose-response and generate a linear rectifier. Cell Syst. 2015;1(3):238–45.
Gebhardt R, Hengstler JG, Muller D, Glockner R, Buenning P, Laube B, et al. New hepatocyte in vitro systems for drug metabolism: metabolic capacity and recommendations for application in basic research and drug development, standard operating procedures. Drug Metab Rev. 2003;35:145–213.
We gratefully acknowledge Martina Suetterlin-Hachmann (Novartis, Basel, Switzerland) for providing fresh rat lung and liver tissues.
No source of funding.
Conflict of interest
R. Murgasova, E. Tor Carrera and J. Bourgailh declare no conflict of interest.
Animal experiments were approved by the local Animal Welfare Committee. All applicable international, national, and/or institutional guidelines for care and use of animals were followed.
About this article
Cite this article
Murgasova, R., Tor Carreras, E. & Bourgailh, J. In Vitro Monitoring of the Mitochondrial Beta-Oxidation Flux of Palmitic Acid and Investigation of Its Pharmacological Alteration by Therapeutics. Eur J Drug Metab Pharmacokinet 43, 675–684 (2018). https://doi.org/10.1007/s13318-018-0479-5